Detect emerging drop-off, understand the likely barrier, and act before the outcome and the revenue are gone.
They miss a lab. They skip a titration check. They go quiet after the first plateau. Weeks later the clinic sees a cancelled renewal and calls it churn.
Signals, not schedules. Synarmic surfaces the patterns associated with emerging drop-off. Moments in orange go to your care team for clinical review, never to automation alone.
A missed lab lives in one system, a skipped visit in another, a stalled refill in a third. Apart, each looks like noise. Joined, they are a patient about to disappear.
Synarmic reads the systems you already use, joins the signals scattered across them, and gives your designated owner one ordered queue in a lightweight portal, with review cases routed into the agreed workflow where configured.
Synarmic detects emerging drop-off, infers the likely barrier, and takes the next approved action. When the inferred barrier matches a protocol your clinic has approved, the corresponding message is sent automatically by email or SMS. Clinically consequential, sensitive, or uncertain moments are routed to your care team.
No side effects reported, visits kept, portal still active. The lapse landed the week the program price steps up. Not tolerance, not access.
Hi Maria, it's the team at [Clinic]. We noticed your refill hasn't gone through this month.
If cost is the reason, please tell us. There are usually options, and we would rather work them out with you than have you stop the program.
Reply STOP to opt out.
Outcome: patient replies and the refill resumes. Unaddressed, a lapsed refill quietly becomes a cancelled program.
A clinical symptom, and the evidence does not settle whether this is expected at the current dose. Synarmic does not decide that.
Outcome: a clinician adjusts, pauses, or reassures. An appropriate pause counts as a good outcome here.
Illustrative, not patient data. Your clinic writes and approves every message and intervention rule before launch. Synarmic determines when an approved message is triggered. What patients receive stays yours.
Reminders follow schedules. Synarmic follows signals.
When continuation remains clinically appropriate, the clinical and commercial incentives align.
What better follow-through can mean
What better visibility can mean
Your clinic sets the rules in advance. Where a barrier matches a protocol you approved, the message sends on its own. Where judgment is required, Synarmic sends nothing and your clinicians decide.
Adjust the inputs to match your operation. Illustrative, and replaced with your own data in an Opportunity Assessment.
ILLUSTRATIVE ESTIMATES. NOT A FORECAST OF SYNARMIC PERFORMANCE.
An Opportunity Assessment replaces these inputs with your own program data.
Hormone and broader metabolic protocols are on the expansion path once the approach is proven to transfer on your data. They are not supported workflows today.
One early adherence window, an agreed baseline, and a credible comparison, so your team can see what changed before expanding across programs or locations. It begins with a 30-minute working session on your program structure, enrollment volume, and current follow-up model.